AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.
Nature communications
View this publicationMember, Steering-Committee Member
Medical Faculty, University of Bonn University Hospital of Bonn Venusberg-Campus 1 53127 Bonn
Our mission is to improve the treatment and prolong the survival of cancer patients. Using preclinical cancer models and patient-derived material we aim to decipher the complex interactions between immune cells and cancer cells to identify novel druggable targets. Our current research focuses on understanding the importance of activating receptors in anti-cancer immune responses.
Nature communications
View this publicationNPJ systems biology and applications
View this publicationNature metabolism
View this publication